Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis

De Sain-van der Velden, Monique G.; Kaysen, George A.; Barrett, Hugh A.; Stellaard, Frans; Gadellaa, Mireille M.; Voorbij, Hieronymus A.; Reijngoud, Dirk-Jan; Rabelink, Ton J.
April 1998
Kidney International;Apr1998, Vol. 53 Issue 4, p994
Academic Journal
Examines the factors affecting the levels of low density proteins. Cause of an increased very LDL in nephrotic patients; Influence of synthesis on the levels of LDL; Hallmark of nephrotic syndrome.


Related Articles

  • Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Muso, Eri; Mune, Masatoshi; Fujii, Yasuhiro; Imai, Enyu; Euda, Naohiko; Hatta, Kazuhiro; Imada, Akio; Miki, Shozo; Kuwahara, Takashi; Takamitsu, Yoshihiro; Takemura, Tsukasa; Tsubakihara, Yoshiharu // Kidney International Supplement;Jul1999, Issue 71, pS-122 

    Examines the efficacy of low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Improvement in hyperlipidemia; Evidence of high incidence of remission at short intervals; Decrease in urinary protein.

  • Lipoprotein(a) in nephrotic syndrome. Stenvinkel, Peter; Berglund, Lars; Heimbürger, Olof; Pettersson, Erna; Alvestrand, Anders // Kidney International;Nov1993, Vol. 44 Issue 5, p1116 

    Lipoprotein(a) [Lp(a)) is an independent risk factor for cardiovascular disease, and it has also been speculated that it promotes thrombosis. Recent studies have shown that patients with gross proteinuria have greatly increased plasma levels of Lp(a), but the genesis is obscure. In the present...

  • Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome. Vaziri, Nosratola D.; Kim, Choong H.; Iphan, Dennis; Kim, Sara; Liang, Kaihui // Kidney International;Jul2004, Vol. 66 Issue 1, p262 

    Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome. Background. Nephrotic syndrome is associated with hypercholesterolemia, hypertriglyceridemia, and marked elevations of plasma low-density lipoprotein (LDL) and very low-density...

  • Nephrology.  // Current Medical Literature: Pediatrics;2008, Vol. 21 Issue 3, p107 

    This section presents abstracts of two studies on pediatric nephrology including the oxidative modification of low-density lipoprotein in children with steroid sensitive nephrotic syndrome, and the link between prednisolone dosage and nephrotic syndrome relapse.

  • Down-regulation of hepatic LDL receptor expression in experimental nephrosis. Vaziri, Nosratola D.; Kai Hui Liang // Kidney International;Sep1996, Vol. 50 Issue 3, p887 

    Nephrotic syndrome (NS) is invariably associated with elevation of plasma total and LDL cholesterol concentrations. The present study was carried out to test the hypothesis that nephrotic LDL hypercholesterulemia is, in part, due to acquired LDL receptor (LDLR) deficiency. To this end, hepatic...

  • Lipoprotein(a)- and low-density lipoprotein–derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy? Kronenberg, Florian; Lingenhel, Arno; Lhotta, Karl; Rantner, Barbara; Kronenberg, Martina F.; König, Paul; Thiery, Joachim; Koch, Michael; von Eckardstein, Arnold; Dieplinger, Hans // Kidney International;Jul2004, Vol. 66 Issue 1, p348 

    Lipoprotein(a)- and low-density lipoprotein–derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy? Background. Patients with nephrotic syndrome have the highest lipoprotein(a) [Lp(a)] concentrations known. Lp(a) is an low-density lipoprotein (LDL)-like particle...

  • Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis. OTO, JUN; SUGA, KENICHI; MATSUURA, SATO; KONDO, SHUJI; OHNISHI, YOSHIAKI; INUI, DAISUKE; IMANAKA, HIDEAKI; KAGAMI, SHOJI; NISHIMURA, MASAJI // Journal of Anesthesia;2009, Vol. 23 Issue 2, p284 

    Focal segmental glomerulosclerosis (FSGS) often leads to refractory nephrotic syndrome (NS). A high level of low-density lipoprotein (LDL) is a risk factor for the progression of NS. An 8-year-old girl presented with severe proteinuria refractory to steroid therapy. She was diagnosed with...

  • Treatment of nephrotic hyperlipoproteinemia with gemfibrozil. Groggel, Gerald C.; Cheung, Alfred K.; Ellis-Benigni, Karen; Wilson, Dana E. // Kidney International;Aug1989, Vol. 36 Issue 2, p266 

    Hypercholesterolemia is a known complication of the nephrotic syndrome. Patients with persistent proteinuria and prolonged hypercholesterolemia are probably at increased risk for cardiovascular disease. Until recently there has been no safe and effective treatment for this disorder. The effects...

  • Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome. Liu, Shuman; Vaziri, Nosratola D. // Nephrology Dialysis Transplantation;Mar2014, Vol. 29 Issue 3, p538 

    Background Nephrotic syndrome (NS) leads to elevation of serum total and LDL cholesterol. This is largely due to impaired LDL clearance, which is caused by hepatic LDL receptor (LDLR) deficiency despite normal LDLR mRNA expression, pointing to a post-transcriptional process. The mechanism(s) by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics